academic article

• Potential impact of the COVID-19 pandemic on everyday preferences for persons with cognitive impairment..  International psychogeriatrics.  36:1256-1261. 2023
• Temporal characterization of Alzheimer's Disease with sequences of clinical records..  EBioMedicine.  -. 2023
• Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment..  Frontiers in neurology.  -. 2023
• Pilot Study of Second-Generation DNA Methylation Epigenetic Markers in Relation to Cognitive and Neuropsychiatric Symptoms in Older Adults..  Journal of Alzheimer's disease : JAD.  93:1563-1575. 2023
• Projection of Care Partners' Preferences in the Proxy Assessments of Everyday Preferences for Persons With Cognitive Impairment..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  31:254-263. 2022
• Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia..  Nature communications.  13:-. 2022
• Development and Evaluation of a Natural Language Processing Annotation Tool to Facilitate Phenotyping of Cognitive Status in Electronic Health Records: Diagnostic Study..  Journal of medical Internet research.  24:-. 2022
• Patients asking about APOE gene test results? Here's what to tell them..  Journal of Family Practice.  71:E1-E7. 2022
• Longitudinal Changes in Neuropsychiatric Symptoms: Impact of Discrepancy in Everyday Preferences Between Persons With Cognitive Impairment and Their Care Partners..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  30:619-623. 2021
• Longitudinal differences in everyday preferences: Comparisons between people with cognitive impairment and their care partners..  International journal of geriatric psychiatry.  37. 2021
• Visit-to-Visit Blood Pressure Variability, Neuropathology, and Cognitive Decline..  Neurology.  96:e2812-e2823. 2021
• MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  17:704-715. 2021
• Predictors of the importance of everyday preferences for older adults with cognitive impairment..  International psychogeriatrics.  34:287-294. 2021
• Patterns of anticonvulsant use and adverse drug events in older adults..  Pharmacoepidemiology and drug safety.  30:28-36. 2020
• Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium..  Neurology.  95:e519-e531. 2020
• Differences in Assessment of Everyday Preferences Between People With Cognitive Impairment and Their Care Partners: The Role of Neuropsychiatric Symptoms..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  28:1070-1078. 2020
• Characterizing Clinical and Neuropathological Traits of APOE Haplotypes in African Americans and Europeans..  Journal of Alzheimer's disease : JAD.  78:467-477. 2020
• Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing..  Nature genetics.  51:1423-1424. 2019
• Longitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults..  JAMA network open.  2:-. 2019
• The relation of telomere length at midlife to subsequent 20-year depression trajectories among women..  Depression and anxiety.  36:565-575. 2019
• Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing..  Nature genetics.  51:414-430. 2019
• Poor Performance on a Preoperative Cognitive Screening Test Predicts Postoperative Complications in Older Orthopedic Surgical Patients..  Anesthesiology.  127:765-774. 2017
• Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease..  Nature genetics.  49:1373-1384. 2017
• APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts..  PLoS medicine.  14:-. 2017
• Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study..  Journal of Alzheimer's disease : JAD.  59:975-985. 2017
• Preoperative Cognitive Stratification of Older Elective Surgical Patients: A Cross-Sectional Study..  Anesthesia and analgesia.  123:186-92. 2016
• The Feasibility of At-Home iPad Cognitive Testing For Use in Clinical Trials..  The journal of prevention of Alzheimer's disease.  3:8-12. 2016
• Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring..  Neurobiology of aging.  61-67. 2015
• Rarity of the Alzheimer disease-protective APP A673T variant in the United States..  JAMA neurology.  72:209-16. 2015
• The Influence of Vascular Risk Factors and Stroke on Cognition in Late Life: Analysis of the NACC Cohort..  Alzheimer disease and associated disorders.  29:287-93. 2015
• Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study..  JAMA neurology.  71:1394-404. 2014
• Mild to moderate Alzheimer dementia with insufficient neuropathological changes..  Annals of neurology.  75:597-601. 2014
• Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  22:1642-51. 2014
• SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment..  Current Alzheimer research.  11:785-91. 2014
• Plasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis..  Archives of neurology.  69:824-31. 2012
• The SIST-M: predictive validity of a brief structured clinical dementia rating interview..  Alzheimer disease and associated disorders.  26:225-31. 2012
• The Structured Interview & Scoring Tool-Massachusetts Alzheimer's Disease Research Center (SIST-M): development, reliability, and cross-sectional validation of a brief structured clinical dementia rating interview..  Archives of neurology.  68:343-50. 2011
• The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals..  Cerebral cortex (New York, N.Y. : 1991).  19:497-510. 2008
• Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment..  Archives of general psychiatry.  64:1443-50. 2007